P3 Health Partners Inc. (PIII) Stock Forecast
Data as of Aug 7, 2026Healthcare · Current price $11.45 (+5.10%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
PIII vs Sector & Market
| Metric | PIII | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.50 | 2.25 | 2.42 |
| Analyst Count | 4 | 8 | 18 |
| Target Upside | -9.1% | +16316.2% | +17.2% |
| P/E Ratio | -0.06 | 3.41 | 35.26 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.60B | $1.61B | $1.63B | 1 |
| 2027-12-31 | $1.68B | $1.74B | $1.80B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-17.89 | $-17.69 | $-17.49 | 1 |
| 2027-12-31 | $-0.26 | $-0.26 | $-0.26 | 1 |
Frequently Asked Questions
What is the analyst consensus for PIII?
The consensus among 4 analysts covering P3 Health Partners Inc. (PIII) is Buy with an average price target of $9.00.
What is the highest price target for PIII?
The highest analyst price target for PIII is $14.00.
What is the lowest price target for PIII?
The lowest analyst price target for PIII is $4.00.
How many analysts cover PIII?
4 analysts have issued ratings for P3 Health Partners Inc. in the past 12 months.
Is PIII a buy or sell right now?
Based on 4 analyst ratings, PIII has a consensus rating of Buy (2.50/5) with a -9.1% upside to the consensus target of $9.00.
What are the earnings estimates for PIII?
Analysts estimate PIII will report EPS of $-17.69 for the period ending 2026-12-31, with revenue estimated at $1.61B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.